5,862 Shares in Danaher Corporation $DHR Acquired by Bridgewater Advisors Inc.

Key Points

• Bridgewater Advisors acquired 5,862 Danaher shares worth approximately $1.15 million during the second quarter. Institutional investors collectively own 79.05% of Danaher’s outstanding stock.
• Analysts maintain a generally positive outlook, with Danaher receiving a “Moderate Buy” consensus rating and an average price target of $228.91, despite some recent target-price reductions and a downgrade to “peer perform.”
• Danaher exceeded quarterly expectations, reporting adjusted EPS of $1.94 versus the $1.85 consensus and revenue of $6.26 billion. Revenue increased 5.5% year over year, while the stock recently opened at $202.51.

Bridgewater Advisors Inc. purchased a new stake in Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,862 shares of the conglomerate's stock, valued at approximately $1,153,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. JPL Wealth Management LLC bought a new stake in shares of Danaher during the 3rd quarter worth about $25,000. Main Street Group LTD bought a new position in Danaher in the 1st quarter valued at about $25,000. WFA of San Diego LLC acquired a new stake in Danaher during the second quarter worth approximately $26,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in Danaher during the 4th quarter worth approximately $27,000. 79.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Stifel Nicolaus reduced their price target on Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Wolfe Research downgraded Danaher from an "outperform" rating to a "peer perform" rating in a report on Monday, June 1st. Weiss Ratings upgraded shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, July 15th. Piper Sandler assumed coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a "neutral" rating and a $200.00 price objective for the company. Finally, TD Cowen decreased their target price on shares of Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $228.91.

Danaher Stock Down 0.7%

NYSE DHR opened at $202.51 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The stock has a market capitalization of $142.37 billion, a PE ratio of 35.97, a PEG ratio of 2.52 and a beta of 0.78. The business has a fifty day moving average price of $193.14 and a two-hundred day moving average price of $193.21.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business's revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.77 earnings per share. Equities analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source